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INTRODUCTION
Neurofibromatosis type 1 (NF1), an autosomal dominant genodermatoses associated with RASopathy and having cancer predisposition, is caused by germline mutation of a long tumor suppressor gene NF1 (~60 exons), which encodes a protein neurofibromin. Among the eight clinical types of neurofibromatosis, NF1 is the most common. Epidemiological data suggest that one person in every 3000 births suffer from NF1. [1] Clinically, NF1 patients exhibit features of numerous neurofibromas, Lisch nodules, axillary freckling, café-au-lait spots, and optic gliomas. [2] NF1 patients mostly develop mesenchymal malignancies, such as malignant peripheral nerve sheath tumors. [3, 4] However, carcinomas are quite rare in them. Squamous cell carcinoma (SCC) is even rarer. Till date, only two cases of cutaneous SCC -one in the sole of the foot [5] and the other in the forehead, [6] have been reported in NF1 patients. This case is the first case of SCC of oral cavity affecting tongue in an NF1 patient.
CASE HISTORY

Patient
Study protocol was approved by Ethics Committee. A 35-year-old male, without any oral deleterious habit, reported to the Department of Oral Pathology of the tertiary care center with a chief complain of a painful ulcer on tongue [ Figure 1c ] and associated difficulty in speech and deglutition for last 1 month. While This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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conducting general survey, he was found to be of average built with all the vital signs within normal limits.
Clinical examination revealed multiple cutaneous non-ulcerated nodules of varying size all along the body [ Figure 1a ], numerous café-au-lait spots over the trunks, limbs and axillary freckling [ Figure 1b ]. Based on the above findings, he was provisionally clinically diagnosed as NF1.
On intraoral examination, a tender ulceroproliferative lesion measuring 2.5 cm × 3.0 cm in greatest dimension with rolled out margins, indurated borders, and surface granularity was noted at posterior one-third of tongue. Clinically, the tongue lesion was diagnosed as a malignant ulcer.
Methods
For confirmation of diagnosis of NF1, the "Diagnostic Criteria for Neurofibromatosis Type 1" [2] was followed.
For confirmation of the diagnosis of tongue ulcer, i n c i s i o n a l b i o p s y f o l l o w e d b y h i s t o p a t h o l o g i c a l
examination was planned. Before collection of biopsy specimen, informed consent of the patient was taken, followed by routine hematological, serological, and coagulation profile evaluation. The biopsied specimen was processed and hematoxylin and eosin staining was done. Immunohistochemistry (IHC) for cytokeratin (Pan CK) and beta-catenin was also performed.
RESULTS
Clinical diagnosis of NF1 was confirmed as patient met the "Diagnostic Criteria for Neurofibromatosis Type 1" [ Table 1 ].
Histopathological examination of the biopsied specimen revealed the features of infiltrating SCC [ Figure 2a ]. Diagnosis of SCC was confirmed by strong positivity for Pan CK [ Figure 2b ]. Beta-catenin IHC staining shows moderate to weak diffuse cytoplasmic positivity [ Figure 2c ].
From the above results, it can be concluded that the NF1 patient was suffering from tongue SCC. 
DISCUSSION
NF1, a complex syndrome caused by loss of function mutation in NF1 gene leading to haploinsufficiency is still an enigmatic disease from the pathophysiological point of view. The large size of the gene, comparative lack of mutational hotspots, and a panoply of pathogenic mutations can be held responsible for this biological complexities regarding pathogenesis of NF1 and its predisposition to cancer.
Since the mapping of the NF1 gene in the year 1987, many scientific papers depicting the association of various oncogenic pathways with this gene have been published.
Among them, the most cited explanation is centered around the interaction between neurofibromin and RAS/mitogen-activated protein kinase (MAPK) pathway. The protein neurofibromin, encoded by NF1 gene, acts as an inhibitor of the RAS/MAPK pathway, which is responsible for transmission of mitogenic signals to the nucleus. [7] Growth factors, after binding with their cell surface receptors, cause activation of RAS, which, in turn, activates the Raf-MAK (mitogen-activated kinase)/MEK pathway and stimulate extracellular signal-related kinase (ERK). ERK enters the nucleus of the cell and initiates transcription. Now, neurofibromin downregulates RAS by conversion of guanosine triphosphate to guanosine diphosphate. When there is a lack of expression of neurofibromin protein due to mutated NF1 gene, the inhibitory signal over the RAS/MAPK pathway is lost resulting in uninterrupted transmission of mitogenic signals to the nucleus, thereby resulting in uncontrolled proliferation.
WNT signaling pathway activation has also been investigated in the context of carcinogenesis in NF1. [8] The study conducted by Armelle Luscan et al. (2014) revealed autonomous activation of WNT pathway in NF1 gene knocked down Schwann cells. The study also showed that there was increased expression of active beta-catenin protein when NF1 was silenced. So, they concluded and tried to establish that NF1 alters WNT pathway and favors tumorigenesis. [9] Another protein, heat shock factor 1 (HSF1), is overexpressed in NF1, which helps in combating the intrinsic stresses produced within the tumor cells, there by favoring their survival.
MicroRNA (miR) has important role in pathogenesis of cancer by post-transcriptional inactivation of messenger RNA of neurofibromin protein in NF1 patients. miR-193a, miR-365-2, and miR-10b are the important miRNAs reported to be dysregulated in NF1-associated cancer.
In this study, we have tried to explore the probable carcinogenesis pathway in NF1 syndrome [ Figure 3 ]. In doing so, it was found that beta-catenin antibody showed a diffuse cytoplasmic positivity in the neoplastic epithelial cells in IHC staining. Overexpression of beta-catenin in the neoplastic cells of tongue SCC is in tune with previously explained WNT pathway activation in NF1 syndrome. However, this does not indicate that other pathways remained silent. Considering the age and absence of oral deleterious habits in this patient, it can be inferred that NF1 loss might be a principal factor in oral carcinogenesis.
As far as our study is concerned, till date, this is the first reported case of tongue SCC in a NF1 patient. So, to conclude, NF1 patients must be followed up at regular intervals to diagnose not only sarcomatous lesions at an early stage but also SCC including OSCC.
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